{"product_id":"retatrutide-ly3437943-p1230","title":"Retatrutide (LY3437943)","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003eRetatrutide (LY3437943) acts as a triple agonist peptide of the glucagon receptor (GCGR), glucagon-like peptide-1 receptor (GLP-1R) and glucosedependent insulinotropic polypeptide receptor (GIPR). The mapped target for this entry is Glucagon receptor; GLP-1 receptor; GIP receptor (GCGR, GLP1R, and GIPR). This target context is most often investigated as part of ligand-responsive signaling, where receptor occupancy can reshape downstream second-messenger output, trafficking, secretion, excitability, or transcriptional programs. Researchers commonly place this biology in metabolic studies, where peptide-driven pathway changes influence hormone-responsive signaling, glucose handling, and energy-balance phenotypes. For experimental design, that means the peptide is often chosen to compare acute signaling with longer adaptive responses in the same system.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003eIts triple-agonist profile makes it relevant to experiments that examine integrated pathway control rather than single-receptor biology alone, especially when phenotypes depend on combined endocrine signaling inputs. In practice, dose-response design, timing, and matched control conditions are important for separating direct target engagement from delayed compensatory responses. Because more than one mapped molecular node is represented in the enrichment, pathway readouts should be interpreted with awareness that the phenotype may integrate multiple signaling inputs.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003epair peptide treatment with pathway-proximal signaling or trafficking readouts whenever possible\u003c\/li\u003e\n\u003cli\u003ecompare responses across cell states or model systems with different receptor abundance\u003c\/li\u003e\n\u003cli\u003edistinguish primary target engagement from downstream adaptation during longer incubations\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003eExperimental interpretation should therefore connect early pathway changes with later phenotypic outputs, rather than relying on a single endpoint in isolation.\u003c\/p\u003e\u003ch2\u003eFormat Considerations\u003c\/h2\u003e\u003cp\u003eThe standard product format is most useful for reproducible baseline experiments, matched comparative studies, and workflows that need a consistent reagent across assay repeats. In comparative workflows, consistency of preparation, exposure window, and matched controls is often as important as the nominal treatment itself. This is particularly helpful for comparative experiments, benchmark studies, and orthogonal validation in which small differences in formulation or handling can complicate interpretation. For peptide-centered workflows, conclusions are usually strongest when biological readouts are paired with consistent preparation and appropriately matched reference conditions.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"1 mg","offer_id":57636822843737,"sku":"P1230-1MG","price":193.0,"currency_code":"EUR","in_stock":true},{"title":"5 mg","offer_id":57636822876505,"sku":"P1230-5MG","price":341.0,"currency_code":"EUR","in_stock":true},{"title":"25 mg","offer_id":57636822909273,"sku":"P1230-25MG","price":763.0,"currency_code":"EUR","in_stock":true},{"title":"100 mg","offer_id":57636822942041,"sku":"P1230-100MG","price":1739.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/P1230-Retatrutide-LY3437943-chemical-structure-tube.png?v=1774212395","url":"https:\/\/absource.de\/products\/retatrutide-ly3437943-p1230","provider":"Absource Diagnostics","version":"1.0","type":"link"}